Westminster Pharmaceuticals Recalls Thyroid Tablets Due to Incorrect Dosage
Westminster Pharmaceuticals recalls 100-count thyroid tablets that may have incorrect dosage levels. This could lead to under or overmedication if used without proper medical supervision.
Lower-risk recall
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Contact the company
What happened, in plain English
Westminster Pharmaceuticals is recalling thyroid medication tablets that may contain incorrect dosage levels. This could cause under or overmedication if taken without proper medical supervision. Read more at govinfonow.com/recall/39761-westminster-pharmaceuticals-recalls-thyroid-tablets-due-to-incorrect-dosage.
Source Summary by GovInfoNow · govinfonow.com/recall/39761-westminster-pharmaceuticals-recalls-thyroid-tablets-due-to-incorrect-dosage · Updated October 6, 2026 · FDA enforcement record: FDA #D-1178-2018
Cite this page
“Westminster Pharmaceuticals Recalls Thyroid Tablets Due to Incorrect Dosage.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39761-westminster-pharmaceuticals-recalls-thyroid-tablets-due-to-incorrect-dosage. Based on FDA recall #D-1178-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1178-2018%22&limit=1).
Why it’s dangerous
The medication was manufactured with an adulterated active ingredient and failed content uniformity tests. This means the actual dosage may be higher or lower than labeled, potentially causing under or overmedication.
Who’s affected
People prescribed thyroid medication by a doctor who own or use these specific 100-count bottles. Those with thyroid conditions are most at risk.
How to tell if you have this one
Check for the product name 'Levothyroxine and Liothyronine (Thyroid Tablets, USP)', 1 grain (60 mg), 100-count bottles, and the specific lot numbers listed in the recall notice.
- Brand
Westminster Pharmaceuticals- Category
Drug
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
Nationwide in the USA and Puerto Rico
| Recall number | Product, codes & lots |
|---|---|
| D-1178-2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-156-04.; Lot #: 15617VP03, 15617VP01, 15617VP-02, Exp 7/31/2019; 15617VP06, 15617VP05, Exp 11/30/2019; 15617VP04, 15618004, 15618002, Exp 12/31/2019; 15618009, 15618008, Exp 2/29/2020; 15618011, Exp 3/31/2020. |
| D-1179-2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.; Lot #: 15717VP-01, 15717VP-02, 15717VP-03, Exp 7/31/2019; 15717002, Exp 12/31/2019; 15718004, Exp 3/31/2020. |
| D-1180-2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.; Lot #: 15517VP01, 15517VP02, 15517VP03, Exp 8/31/2019; 15518001, Exp 12/31/2019; 15518002, Exp 3/31/2020. |
| D-1181-2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.; Lot #: 15917VP03, 15917VP02, 15917VP01, Exp 10/31/2019; 15918004, 15918003, 15918002, 15918001, Exp 12/31/2019; 15918VP03, 15918VP02, 15918VP01, 15918005, Exp 2/29/2020; 15918007, 15918006, Exp 3/31/2020. |
| D-1182-2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.; Lot #: 15817VP-01, 15817VP-02, 15817VP-03, Exp 9/30/2019; 15818001, Exp 3/31/2020. |
What to do — step by step
Check Medication Details
Look for the product name, dosage, and lot numbers listed in the recall notice to confirm if your medication is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class I
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1178-2018 (August 3, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1178-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.